Northrop Grumman, US6668071029

Northrop Grumman stock holds near 52-week high after solid Q2 results

Published on 09/07/2026 at 13:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Northrop Grumman stock is trading close to its 52-week high after the defense group reported solid second-quarter 2026 results with higher sales and earnings, keeping the focus on margins, cash flow and its role in U.S. defense spending.

Militärjet und Radarturm auf Wüstenflugplatz bei Sonnenuntergang
Northrop Grumman US6668071029 zeigt generischen Militärjet neben Radaranlage bei Sonnenuntergang auf Wüstenflugplatz, Illustration mit AI erstellt.

Northrop Grumman stock (ISIN US6668071029) is trading at 595.05 USD on the New York Stock Exchange as of September 7, 2026, only a few dollars below its recent 52-week high around the 600 USD mark, giving the company a market capitalization of about 84.93 billion USD according to TradingView data as of early September 2026. For investors, the main driver remains the company’s solid second-quarter 2026 results, which showed revenue growth and higher earnings compared with the prior year period, underlining Northrop Grumman’s positioning in U.S. defense spending.

Q2 2026 figures underpin valuation

Per the company’s latest quarterly release for the second quarter of 2026, Northrop Grumman reported revenue of approximately 11.2 billion USD for Q2 2026, up about 8.7 percent from around 10.3 billion USD in Q2 2025, reflecting increased volumes in key defense programs and continued demand for advanced systems. Net earnings attributable to shareholders in Q2 2026 came in near 1.4 billion USD, compared with roughly 1.2 billion USD a year earlier, implying earnings growth of about 16.7 percent year-on-year and demonstrating operating leverage as higher sales translated into improved profitability. On a per-share basis, diluted earnings per share for Q2 2026 were approximately 9.10 USD versus about 7.80 USD in Q2 2025, a rise of roughly 16.7 percent, which keeps the valuation metrics in focus for long-term shareholders.

Operating margin for Northrop Grumman in Q2 2026 was around 12.5 percent, slightly higher than the roughly 11.8 percent reported in Q2 2025, indicating that cost discipline and program execution remain important strengths for the group. Free cash flow generation also improved: management reported Q2 2026 free cash flow of approximately 1.1 billion USD, compared with about 0.9 billion USD in the prior-year quarter, an increase of roughly 22.2 percent that gives the company financial flexibility for dividends, share buybacks and investments in new capabilities. For investors looking at defense contractors, this combination of mid-single to high-single digit revenue growth and double-digit earnings and cash flow growth is a key part of the Northrop Grumman equity story.

Guidance and analyst views on Northrop Grumman stock

In its Q2 2026 commentary, Northrop Grumman reaffirmed its full-year 2026 guidance, indicating expected revenue in the range of roughly 44 billion to 46 billion USD and diluted EPS between about 35.50 USD and 36.50 USD, showing confidence in the order book and program execution. Compared with fiscal year 2025 revenue of approximately 41.0 billion USD (historical), the midpoint of the 2026 guidance implies revenue growth of roughly 9.8 percent, while EPS at the midpoint represents a double-digit increase versus the prior year, highlighting management’s expectation of continued margin stability. The guidance suggests that Northrop Grumman aims to sustain growth across segments including aeronautics, space and mission systems, underpinned by long-duration defense contracts.

According to recent coverage from TradingView-linked market data, Northrop Grumman stock has declined by about 1.57 percent over the past week but remains close to its 52-week high, which underscores that the market has already priced in much of the positive news from the last results. The current share price of 595.05 USD compares with a 52-week low near the mid-400 USD range, meaning the stock is trading roughly 30 percent above that low, a level that may prompt investors to scrutinize valuation multiples such as price-to-earnings in light of the company’s earnings trajectory. Analysts following the stock generally continue to emphasize Northrop Grumman’s exposure to U.S. defense budgets and programs such as strategic deterrence and advanced aircraft, but also note that any slowdown in defense spending or delays in contract awards would represent a key risk to the growth outlook.

Defense programs and competitive position

Northrop Grumman’s business model is centered on high-technology defense and aerospace systems, including stealth bombers, missile defense solutions and space systems, which together create a diversified revenue stream tied to long-term government contracts. In Q2 2026, the company highlighted continued progress on major programs and stable demand in mission systems, contributing to the overall revenue increase of 8.7 percent year-on-year. For investors, this mix of stable, contracted revenue and opportunities in emerging areas such as space and cyber-defense supports the view that Northrop Grumman can sustain growth beyond the current fiscal year.

Competition in the defense sector remains intense, with peers in the United States and Europe also vying for large contracts, yet Northrop Grumman’s performance metrics for Q2 2026, including a 12.5 percent operating margin and rising free cash flow, suggest the company is holding its ground effectively. The backlog of contracted work, while not fully detailed in the recent snippets, is typically a key indicator for investors assessing visibility of future revenue; the double-digit earnings growth in Q2 2026 indicates that the current backlog is translating into profitable execution. These fundamentals help explain why the stock price is trading close to the top of its 52-week range despite a modest pullback over the latest week.

Representative product: B-21 Raider bomber program

One representative program for Northrop Grumman is the B-21 Raider stealth bomber, an advanced long-range aircraft developed for the U.S. Air Force and designed to replace older bomber fleets. While the latest Q2 2026 report does not attach a single revenue figure solely to the B-21 program in the available snippets, management has previously emphasized that development and early production activities for B-21 contribute meaningfully to the aeronautics segment’s sales and margins. For investors, the B-21 illustrates how Northrop Grumman’s expertise in stealth, systems integration and mission effectiveness can translate into long-duration contracts that support revenue growth and earnings visibility over many years.

Northrop Grumman stock price and market data

As of September 7, 2026, Northrop Grumman stock is quoted at 595.05 USD on the NYSE, with the latest market data showing a small daily decline of around 0.15 percent compared with the prior close, and a market capitalization of about 84.93 billion USD. The share price, sitting only slightly below a 52-week high in the 600 USD area and roughly 30 percent above the 52-week low, reflects investors’ recognition of the company’s double-digit earnings growth and robust cash generation in Q2 2026 while also embedding expectations for continued execution on major defense programs. For retail investors watching Northrop Grumman stock, the key questions now revolve around whether the company can deliver on its full-year 2026 guidance and sustain margins, given the high valuation implied by the share price near its peak.

Northrop Grumman stock at a glance

  • Company: Northrop Grumman Corporation
  • ISIN: US6668071029
  • Ticker: NOC
  • Trading venue: NYSE
  • Price (as of September 7, 2026): 595.05 USD
  • Market capitalization: 84.93 billion USD (as of September 7, 2026)
  • Sector / Industry: Aerospace and Defense
  • Index membership: S&P 500

More news and analyses on Northrop Grumman stock

Disclaimer...

en | US6668071029 | NORTHROP GRUMMAN | boerse | 70062994 | bgmi